HomeBBIO • NASDAQ
add
BridgeBio Pharma Inc
Previous close
$61.37
Day range
$60.74 - $63.41
Year range
$21.72 - $69.48
Market cap
12.20B USD
Avg Volume
2.42M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 120.70M | 4,318.01% |
Operating expense | 250.50M | 32.35% |
Net income | -182.74M | -12.78% |
Net profit margin | -151.40 | 97.45% |
Earnings per share | -0.72 | 33.41% |
EBITDA | -134.96M | 27.28% |
Effective tax rate | 0.83% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 645.94M | 142.54% |
Total assets | 998.25M | 50.12% |
Total liabilities | 2.92B | 55.09% |
Total equity | -1.92B | — |
Shares outstanding | 192.71M | — |
Price to book | -6.12 | — |
Return on assets | -32.80% | — |
Return on capital | -4,021.17% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -182.74M | -12.78% |
Cash from operations | -109.57M | 39.32% |
Cash from investing | 4.46M | -88.32% |
Cash from financing | -894.00K | -226.45% |
Net change in cash | -106.00M | 25.16% |
Free cash flow | -74.83M | 28.01% |
About
CEO
Founded
2015
Headquarters
Website
Employees
728
